IRLAB Therapeutics AB (publ)
SSE:IRLAB-A.ST
14.45 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 111.309 | 252.776 | 401.897 | 277.009 | 110.527 | 134.442 | 74.709 | 25.736 | 14.424 | 19.667 | 0 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 111.309 | 252.776 | 401.897 | 277.009 | 110.527 | 134.442 | 74.709 | 25.736 | 14.424 | 19.667 | 0 |
| Net Receivables
| 12.278 | 12.217 | 17.033 | 4.712 | 7.687 | 4.359 | 1.816 | 1.222 | 0.694 | 0 | 0 |
| Inventory
| 0.001 | 3.692 | 2.509 | 2.019 | 0 | 1.67 | -1.816 | -1.222 | -0.694 | 0 | 0 |
| Other Current Assets
| -0.001 | -0.001 | 0.001 | 0.001 | 1.664 | -0.001 | 3.515 | 2.458 | 1.651 | 1.441 | 0 |
| Total Current Assets
| 123.587 | 268.684 | 421.44 | 283.741 | 119.878 | 140.47 | 78.224 | 28.194 | 16.075 | 21.108 | 0 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 6.672 | 8.009 | 8.348 | 4.317 | 5.919 | 1.197 | 0.478 | 0.649 | 0.747 | 1.051 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 46.862 | 46.862 | 42.661 | 82.011 | 82.27 | 83.269 | 84.269 | 84.269 | 84.269 | 84.269 | 0 |
| Goodwill and Intangible Assets
| 46.862 | 46.862 | 42.661 | 82.011 | 82.27 | 83.269 | 84.269 | 84.269 | 84.269 | 84.269 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | -54.871 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0 | 24.999 |
| Total Non-Current Assets
| 53.534 | 54.871 | 51.009 | 86.328 | 88.189 | 84.466 | 84.747 | 84.918 | 85.017 | 85.32 | 24.999 |
| Total Assets
| 177.121 | 323.555 | 472.449 | 370.068 | 208.067 | 224.936 | 162.971 | 113.112 | 101.092 | 106.428 | 24.999 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 33.792 | 10.031 | 12.302 | 3.683 | 8.438 | 5.997 | 4.099 | 4.729 | 1.961 | 1.697 | 0 |
| Short Term Debt
| 2.94 | 3.595 | 3.034 | 1.657 | 1.643 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 48.42 | 11.805 | 7.814 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| -0.001 | 18.717 | 5.646 | 3.773 | 5.445 | 6.463 | 3.872 | 4.094 | 3.323 | 3.642 | 0.007 |
| Total Current Liabilities
| 36.731 | 32.343 | 69.402 | 20.918 | 23.34 | 12.46 | 7.971 | 8.823 | 5.284 | 5.339 | 0.007 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 24.511 | 0.381 | 3.566 | 1.27 | 2.9 | 0 | 0 | 0.4 | 0.4 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.4 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.381 | 10.633 | 0 |
| Other Non-Current Liabilities
| 0.115 | 0 | 0 | 0 | 0 | 5.997 | 4.099 | 0 | 0.4 | 1.883 | 0 |
| Total Non-Current Liabilities
| 24.626 | 0.381 | 3.566 | 1.27 | 2.9 | 5.997 | 4.099 | 0.4 | 3.781 | 12.516 | 0 |
| Total Liabilities
| 61.357 | 32.724 | 72.968 | 22.188 | 26.24 | 12.46 | 7.971 | 9.223 | 9.065 | 17.855 | 0.007 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 1.037 | 1.037 | 1.035 | 1.035 | 0.862 | 0.81 | 0.7 | 0.507 | 0.181 | 0.084 | 0.05 |
| Retained Earnings
| -575.478 | -400.411 | -287.004 | -338.786 | -247.133 | -151.013 | -76.914 | -20.689 | 22.007 | 2.676 | -0.008 |
| Accumulated Other Comprehensive Income/Loss
| -0 | 0.001 | -0 | 0.065 | 0.001 | 0 | 0 | -0 | 69.954 | 0.034 | 0 |
| Other Total Stockholders Equity
| 690.205 | 690.204 | 685.45 | 685.566 | 428.096 | 362.679 | 231.214 | 124.071 | -0.115 | 47.772 | 24.95 |
| Total Shareholders Equity
| 115.764 | 290.831 | 399.481 | 347.88 | 181.826 | 212.476 | 155 | 103.889 | 92.027 | 50.566 | 24.992 |
| Total Equity
| 115.764 | 290.831 | 399.481 | 347.88 | 181.826 | 212.476 | 155 | 103.889 | 92.027 | 88.573 | 24.992 |
| Total Liabilities & Shareholders Equity
| 177.121 | 323.555 | 472.449 | 370.068 | 208.066 | 224.936 | 162.971 | 113.112 | 101.092 | 106.428 | 24.999 |